Daily Medication Pearl: Sacituzumab govitecan-hziy (Trodelvy) for Breast Cancer
November 16th 2021Sacituzumab govitecan-hziy is indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer who have received 2 or more prior systemic therapies, at least 1 of which for metastatic disease.
Read More
New Rules on Mandatory COVID-19 Vaccinations: Applicability to Pharmacies
November 15th 2021CMS Interim Final Rule on mandatory COVID-19 vaccinations for all facilities participating in Medicare and Medicaid potentially impacts pharmacies that provide services under a contract or arrangement with these facilities.
Read More
Help Patients Safely Handle Medications to Improve Adherence
Addressing barriers such as cognitive impairment, cultural issues, and denial can help patients avoid adverse effects.
Read More